<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bryen SJ</submitter><funding>National Eye Institute</funding><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHGRI NIH HHS</funding><funding>National Health and Medical Research Council</funding><funding>National Institutes of Health</funding><funding>National Human Genome Research Institute</funding><funding>Muscular Dystrophy Association</funding><pagination>553-559</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10101692</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>103(5)</volume><pubmed_abstract>EMC1 encodes subunit 1 of the endoplasmic reticulum (ER) membrane protein complex (EMC), a transmembrane domain insertase involved in membrane protein biosynthesis. Variants in EMC1 are described as a cause of global developmental delay, hypotonia, cortical visual impairment, and commonly, cerebral atrophy on MRI scan. We report an individual with severe global developmental delay and progressive cerebellar atrophy in whom exome sequencing identified a heterozygous essential splice-site variant in intron-3 of EMC1 (NM_015047.3:c.287-1G>A). Whole genome sequencing (WGS) identified a deep intronic variant in intron-20 of EMC1 (NM_015047.3:c.2588-771C>G) that was poorly predicted by in silico programs to disrupt pre-mRNA splicing. Reverse Transcription-PCR (RT-PCR) revealed stochastic activation of a pseudo-exon associated with the c.2588-771C>G variant and mis-splicing arising from the c.287-1G>A variant. This case highlights the utility of WGS and RNA studies to identify and assess likely pathogenicity of deep intronic variants and expands the genotypic and phenotypic spectrum of EMC1-related disorders.</pubmed_abstract><journal>Clinical genetics</journal><pubmed_title>Compound heterozygous splicing variants expand the genotypic spectrum of EMC1-related disorders.</pubmed_title><pmcid>PMC10101692</pmcid><funding_grant_id>U01 HL120393</funding_grant_id><funding_grant_id>HHSN268201800001C</funding_grant_id><funding_grant_id>R01 HL093093</funding_grant_id><funding_grant_id>R01 HL120393</funding_grant_id><funding_grant_id>R01 HL117626</funding_grant_id><funding_grant_id>R01 HG009141</funding_grant_id><funding_grant_id>R01 HL133040</funding_grant_id><funding_grant_id>contract HHSN268201800002I R01 HL120393</funding_grant_id><funding_grant_id>U01 HL120393; contract HHSN268201800001I</funding_grant_id><funding_grant_id>TOPMed program (R01 HL117626 02S1)</funding_grant_id><funding_grant_id>UM1 HG008900</funding_grant_id><pubmed_authors>Reupena MS</pubmed_authors><pubmed_authors>Zhang K</pubmed_authors><pubmed_authors>Cooper ST</pubmed_authors><pubmed_authors>Naseri T</pubmed_authors><pubmed_authors>Viali S</pubmed_authors><pubmed_authors>Dziaduch G</pubmed_authors><pubmed_authors>Evesson FJ</pubmed_authors><pubmed_authors>Bryen SJ</pubmed_authors><pubmed_authors>Bommireddipalli S</pubmed_authors><pubmed_authors>Minster RL</pubmed_authors><pubmed_authors>O'Grady GL</pubmed_authors><pubmed_authors>Waddell LB</pubmed_authors><pubmed_authors>Charlton A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Compound heterozygous splicing variants expand the genotypic spectrum of EMC1-related disorders.</name><description>EMC1 encodes subunit 1 of the endoplasmic reticulum (ER) membrane protein complex (EMC), a transmembrane domain insertase involved in membrane protein biosynthesis. Variants in EMC1 are described as a cause of global developmental delay, hypotonia, cortical visual impairment, and commonly, cerebral atrophy on MRI scan. We report an individual with severe global developmental delay and progressive cerebellar atrophy in whom exome sequencing identified a heterozygous essential splice-site variant in intron-3 of EMC1 (NM_015047.3:c.287-1G>A). Whole genome sequencing (WGS) identified a deep intronic variant in intron-20 of EMC1 (NM_015047.3:c.2588-771C>G) that was poorly predicted by in silico programs to disrupt pre-mRNA splicing. Reverse Transcription-PCR (RT-PCR) revealed stochastic activation of a pseudo-exon associated with the c.2588-771C>G variant and mis-splicing arising from the c.287-1G>A variant. This case highlights the utility of WGS and RNA studies to identify and assess likely pathogenicity of deep intronic variants and expands the genotypic and phenotypic spectrum of EMC1-related disorders.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-05-28T21:57:03.096Z</modification><creation>2026-04-08T03:19:13.369Z</creation></dates><accession>S-EPMC10101692</accession><cross_references><pubmed>36799557</pubmed><doi>10.1111/cge.14311</doi></cross_references></HashMap>